Webinar: Winning the Launch - Defining Success Beyond Approval for First-Time Launchers

What does it mean to "win" a launch?

As a proud Platinum Sponsor of the First-Time Launch Alliance, NNIT is joining industry experts from Beghou and Sage Advisors for a thought-provoking panel discussion that will challenge traditional definitions of launch success and explore the diverse perspectives that shape organizational decision-making.

For many emerging biopharmaceutical companies, success is often measured by achieving key development milestones such as positive clinical data, a successful NDA/BLA submission, regulatory approval, or manufacturing readiness. Yet industry data consistently demonstrates that many organizations struggle to meet launch expectations even after achieving these milestones. Why?

The reality is that "winning" means different things to different stakeholders.

For Clinical Development teams, success may be advancing a program through key milestones. Regulatory leaders may define success as achieving approval without delays. Manufacturing and Supply Chain organizations focus on reliable product availability and uninterrupted patient access.

Commercial teams evaluate success through market adoption, demand realization, and achieving business objectives. Investors may view success through growth, valuation, or acquisition outcomes. Ultimately, each function participates in a relay race where success depends on effectively passing the baton to the next team.

Participants will examine why strong science alone is not always enough, how organizational silos can undermine launch readiness, and why cross-functional alignment is often the deciding factor between commercial success and commercial disappointment.